With the help of new scientific and technological developments, the HIV/Aids research community is increasingly turning to an ...

Scientists have developed Lenacapavir, a twice-yearly injection that cuts HIV infection risk by 96% in groundbreaking trials.

A first-of-its-kind treatment center aimed at helping those living with or at risk of HIV is now open in Minneapolis.

A man who has lived with HIV for 12 years is part of a campaign to raise awareness of the stigma associated with the ...

In two mid-Michigan school districts where the HIV education curriculum was discovered to be out of date a year ago by 6 News ...

A new HIV prevention drug, lenacapavir, has shown 100% effectiveness in women and near-perfect results in men during trials.

Lenacapavir, a new twice-yearly injection, offers 96% HIV prevention efficacy, surpassing daily oral PrEP. For oral ...

Ending AIDS as a public health threat by 2030 is a real possibility, tantalizingly close. But the job is not yet done.

Atlanta is set to make history this Friday with the first-ever Kiki Exhibition Ball at City Hall, an event celebrating the ...

A second hospital in a county is to offer HIV and hepatitis tests to accident and emergency patients. The year-long project, ...

A collaborative effort by residents and moves to uphold human rights are key to eliminating HIV/Aids as a public health issue ...

As residents come together to recognize World AIDS Day, experts say early detection and modern drug regimens could eventually ...